Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT06864936
What this trial is testing

Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remitting
University of Maryland, Baltimore 30
Not applicableStudy completedNCT06463639
What this trial is testing

FLT3 Clonal Evolution in Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
National Taiwan University Hospital 1,213
Early research (Phase 1)Study completedNCT01016730
What this trial is testing

Bortezomib in Treating Patients With Relapsed or Refractory AIDS-Related Kaposi Sarcoma

Who this might be right for
AIDS-Related Kaposi SarcomaHIV InfectionRecurrent Kaposi Sarcoma
National Cancer Institute (NCI) 24
Not applicableStudy completedNCT05250765
What this trial is testing

Comparison of Efficiency and Effectiveness of Two Types of Bonded Orthodontic Retainers: an RCT.

Who this might be right for
Relapse
University Hospital, Ghent 114
Not applicableNot Yet RecruitingNCT07008872
What this trial is testing

CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute Leukemia

Who this might be right for
CD7+ LymphomaCD7+ Acute Leukemia
Qi deng 40
Testing effectiveness (Phase 2)Ended earlyNCT00462865
What this trial is testing

Trial of Chemotherapy and Avastin as Treatment for Women With Breast Cancer at High Risk for Relapse

Who this might be right for
Breast Cancer
Brown University 18
Testing effectiveness (Phase 2)Study completedNCT04875195
What this trial is testing

Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)

Who this might be right for
Hodgkin's LymphomaPrimary Mediastinal Large B-cell Lymphoma (PMBCL)
Merck Sharp & Dohme LLC 66
Testing effectiveness (Phase 2)Study completedNCT00223639
What this trial is testing

New Medications to Treat Alcohol Dependence

Who this might be right for
Alcoholism
Bankole Johnson 29
Not applicableLooking for participantsNCT07497165
What this trial is testing

Epunamin Combined With DECP for Relapsed/Refractory Multiple Myeloma

Who this might be right for
Relapsed/Refractory Multiple Myeloma (RRMM)Multiple Myeloma
Shanxi Bethune Hospital 48
Early research (Phase 1)Not Yet RecruitingNCT07335328
What this trial is testing

Fully Human Bispecific Anti-CD20, Anti-CD19 CAR T Cells for Patients With Relapsed and/or Refractory B Cell Malignancies

Who this might be right for
B-cell Non Hodgkin Lymphoma
Medical College of Wisconsin 24
Testing effectiveness (Phase 2)Study completedNCT01242631
What this trial is testing

Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer

Who this might be right for
Testicular CancerGerm Cell Cancer
Hannover Medical School 25
Large-scale testing (Phase 3)Study completedNCT02883153
What this trial is testing

Zirconium-89-girentuximab PET/CT Imaging in Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Radboud University Medical Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT06854445
What this trial is testing

Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse Large B-cell Lymphoma

Who this might be right for
Diffuse Large Cell B-lymphoma
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. 55
Large-scale testing (Phase 3)Ended earlyNCT00418145
What this trial is testing

Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks

Who this might be right for
Multiple Sclerosis
Fred Lublin 16
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06330077
What this trial is testing

Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis

Who this might be right for
Multiple SclerosisRemitting Relapsing Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 60
Early research (Phase 1)Study completedNCT00509353
What this trial is testing

N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma

Who this might be right for
Neuroblastoma
New Approaches to Neuroblastoma Therapy Consortium 26
Large-scale testing (Phase 3)Study completedNCT01917019
What this trial is testing

A Safety and Efficacy Study of Oral Prolonged-Release Fampridine (BIIB041) in Japanese Participants With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Remittent ProgressiveMultiple Sclerosis, Primary ProgressiveRelapsing-Remitting Multiple Sclerosis+2 more
Biogen 101
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)UnknownNCT05155839
What this trial is testing

Safety and Preliminary Efficacy Study of MRG001 in Patients With Non-Hodgkin Lymphoma (NHL)

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (NHL)
Shanghai Miracogen Inc. 108
Early research (Phase 1)UnknownNCT05731219
What this trial is testing

UTAA06 Injection in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Relapsed/Refractory Acute Myeloid Leukemia
PersonGen BioTherapeutics (Suzhou) Co., Ltd. 18
Next Page